Technology Assessment Using Insurance Claims: Example of Prostatectomy

This article describes the findings of an ongoing assessment of prostatectomy that relied on the use of administrative data bases. Examples of the use of claims data for monitoring outcomes and treatment comparisons are provided, as well as a discussion of the strengths and limitations of administrative data for technology assessment.

[1]  D. Byar.  Why data bases should not replace randomized clinical trials. , 1980, Biometrics.

[2]  J. Wennberg,et al.  Dealing with medical practice variations: a proposal for action. , 1984, Health affairs.

[3]  D. Hanley,et al.  Symptom status and quality of life following prostatectomy. , 1988, JAMA.

[4]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[5]  P Paul-Shaheen,et al.  Small area analysis: a review and analysis of the North American literature. , 1987, Journal of health politics, policy and law.

[6]  R H Brook,et al.  Variations in the use of medical and surgical services by the Medicare population. , 1986, The New England journal of medicine.

[7]  D. K. Williams,et al.  Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities. , 1988, JAMA.

[8]  James M. Hatten.  Medicare's Common Denominator: The Covered Population , 1980, Health care financing review.

[9]  K E Stanley,et al.  Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.

[10]  L L Roos,et al.  Using administrative data for longitudinal research: comparisons with primary data collection. , 1987, Journal of chronic diseases.

[11]  W. Roper,et al.  Effectiveness in Health Care , 1988 .

[12]  M. Barry,et al.  Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. , 1988, JAMA.

[13]  F. Mosteller,et al.  Costs, Risks, and Benefits of Surgery , 1977 .

[14]  D McLerran,et al.  Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis. , 1990, The Journal of urology.

[15]  D M Eddy,et al.  The quality of medical evidence: implications for quality of care. , 1988, Health affairs.

[16]  Nicholas L. Tilney,et al.  The high cost of low-frequency events: the anatomy and economics of surgical mishaps. , 1981, The New England journal of medicine.

[17]  J. Lave,et al.  The Potential Use of Health Care Financing Administration Data Sets for Health Care Services Research , 1983, Health care financing review.

[18]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.

[19]  Experiences with evaluating the safety and efficacy of medical technologies. , 1984, Annual review of public health.

[20]  N. Roos,et al.  Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. , 1987, JAMA.